A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Clinics |
Texto Completo: | https://www.revistas.usp.br/clinics/article/view/19558 |
Resumo: | OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL. |
id |
USP-19_9f20212bf8821e6de21459eb2df4e682 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/19558 |
network_acronym_str |
USP-19 |
network_name_str |
Clinics |
repository_id_str |
|
spelling |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval Target-Controlled InfusionPropofolRemifentanilOocyte RetrievalSedation OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2011-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1955810.1590/S1807-59322011000500017Clinics; v. 66 n. 5 (2011); 811-815 Clinics; Vol. 66 Núm. 5 (2011); 811-815 Clinics; Vol. 66 No. 5 (2011); 811-815 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19558/21621Coskun, DemetGunaydin, BerrinTas, AycaInan, GozdeCelebi, HulyaKaya, Kadirinfo:eu-repo/semantics/openAccess2012-05-23T16:48:37Zoai:revistas.usp.br:article/19558Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-23T16:48:37Clinics - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
title |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
spellingShingle |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval Coskun, Demet Target-Controlled Infusion Propofol Remifentanil Oocyte Retrieval Sedation |
title_short |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
title_full |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
title_fullStr |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
title_full_unstemmed |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
title_sort |
A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval |
author |
Coskun, Demet |
author_facet |
Coskun, Demet Gunaydin, Berrin Tas, Ayca Inan, Gozde Celebi, Hulya Kaya, Kadir |
author_role |
author |
author2 |
Gunaydin, Berrin Tas, Ayca Inan, Gozde Celebi, Hulya Kaya, Kadir |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Coskun, Demet Gunaydin, Berrin Tas, Ayca Inan, Gozde Celebi, Hulya Kaya, Kadir |
dc.subject.por.fl_str_mv |
Target-Controlled Infusion Propofol Remifentanil Oocyte Retrieval Sedation |
topic |
Target-Controlled Infusion Propofol Remifentanil Oocyte Retrieval Sedation |
description |
OBJECTIVE: To evaluate the effects of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion on hemodynamic parameters, pain, sedation, and recovery score during oocyte retrieval. METHODS: Sixty-nine women were scheduled for oocyte retrieval. Target-controlled propofol infusion at an effectsite concentration of 1.5 μg/mL was instituted. The patients were randomly allocated to receive remifentanil at an effect-site concentration of either 1.5 (group I, n = 23), 2 (group II, n = 23) or 2.5 ng/mL (group III, n = 23). Hemodynamic variables, sedation, pain, the Aldrete recovery score, and side effects were recorded. RESULTS: Hemodynamic variables, sedation and pain scores and the number of patients with the maximum Aldrete recovery score 10 min after the procedure were comparable among the groups. The number of patients in group III with the maximum Aldrete recovery score 5 min after the procedure was significantly lower than that in groups I and II. One patient in group II and one patient in group III suffered from nausea. CONCLUSION: Similar pain-free conscious sedation conditions without significant changes in hemodynamic parameters were provided by all three protocols. However, target controlled infusion of remifentanil at 1.5 or 2 ng/mL proved superior at providing early recovery compared to 2.5 ng/mL. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/19558 10.1590/S1807-59322011000500017 |
url |
https://www.revistas.usp.br/clinics/article/view/19558 |
identifier_str_mv |
10.1590/S1807-59322011000500017 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/clinics/article/view/19558/21621 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
publisher.none.fl_str_mv |
Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo |
dc.source.none.fl_str_mv |
Clinics; v. 66 n. 5 (2011); 811-815 Clinics; Vol. 66 Núm. 5 (2011); 811-815 Clinics; Vol. 66 No. 5 (2011); 811-815 1980-5322 1807-5932 reponame:Clinics instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Clinics |
collection |
Clinics |
repository.name.fl_str_mv |
Clinics - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
||clinics@hc.fm.usp.br |
_version_ |
1787713174077702144 |